Noah Younger, MD, PhD
Instructor of Medicine, Div. of Hematology & Oncology, UCSF
Education
02/2024 - Hematology and Oncology, University of California, San Francisco
06/2020 - Internal Medicine, University of California, San Francisco
MD, 06/2017 - Medicine, University of California, San Francisco
PhD, 04/2015 - Chemical Biology, University of California, San Francisco
Honors & Awards
- Conquer Cancer Young Investigator Award, ASCO, 2024-2025
- Young Investigator Award, Prostate Cancer Foundation, 2023-2026
Selected Publications
- Lundberg A, Zhang M, Aggarwal R, Li H, Zhang L, Foye A, Sjöström M, Chou J, Chang K, Moreno-Rodriguez T, Shrestha R, Baskin A, Zhu X, Weinstein AS, Younger N, Alumkal JJ, Beer TM, Chi KN, Evans CP, Gleave M, Lara PN, Reiter RE, Rettig MB, Witte ON, Wyatt AW, Feng FY, Small EJ, Quigley DA. The Genomic and Epigenomic Landscape of Double-Negative Metastatic Prostate Cancer. Cancer Res. 2023 08 15; 83(16):2763-2774. View on PubMed
- Chen L, Shu Y, Liang X, Chen EC, Yee SW, Zur AA, Li S, Xu L, Keshari KR, Lin MJ, Chien HC, Zhang Y, Morrissey KM, Liu J, Ostrem J, Younger NS, Kurhanewicz J, Shokat KM, Ashrafi K, Giacomini KM. OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proc Natl Acad Sci U S A. 2014 Jul 08; 111(27):9983-8. View on PubMed